Simplex Trading
JBIO

Simplex Trading’s Jade Biosciences JBIO Stock Holding History

Simplex Trading’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$416K Hold
18,700
– – ﹤0.01% 3839
2026
Q1 		$263K Hold
18,700
– – ﹤0.01% 3972
2025
Q4 		$289K Sell
18,700
-5,000
-21% -$58.7K ﹤0.01% 3858
2025
Q3 		$204K Sell
23,700
-2,200
-8% -$18K ﹤0.01% 4914
2025
Q2 		$258K Buy
25,900
+25,309
+4,282% +$861K ﹤0.01% 4231
2025
Q1 		$7K Buy
591
+57
+11% +$5.01K ﹤0.01% 7288
2024
Q4 		$49K Buy
+534
New +$46K ﹤0.01% 5879
2024
Q3 		– Sell
-217
Closed -$12K – 8439
2024
Q2 		$12K Buy
+217
New +$144K ﹤0.01% 7279

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Simplex Trading's JBIO Position: Q2 2026 in Review

Simplex Trading sold out of Jade Biosciences (JBIO) in Q2 2026, closing a stake of 83 shares — an estimated $1.73K sold.

Simplex Trading first reported a position in JBIO in Q2 2024 and held it in 6 quarters. The position peaked at $49K in Q4 2024. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Simplex Trading reported no remaining Jade Biosciences position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 83 Jade Biosciences shares in Q2 2026, an estimated $1.73K.
  • Simplex Trading first reported a position in Jade Biosciences in Q2 2024 and held it in 6 quarters.
  • Simplex Trading's Jade Biosciences position peaked at $49K in Q4 2024.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.